Logo image of CHRD

CHORD ENERGY CORP (CHRD) Stock Fundamental Analysis

NASDAQ:CHRD - Nasdaq - US6742152076 - Common Stock - Currency: USD

104.08  -0.51 (-0.49%)

After market: 104.08 0 (0%)

Fundamental Rating

5

Overall CHRD gets a fundamental rating of 5 out of 10. We evaluated CHRD against 213 industry peers in the Oil, Gas & Consumable Fuels industry. CHRD has an average financial health and profitability rating. CHRD scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year CHRD was profitable.
CHRD had a positive operating cash flow in the past year.
Of the past 5 years CHRD 4 years were profitable.
CHRD had a positive operating cash flow in each of the past 5 years.
CHRD Yearly Net Income VS EBIT VS OCF VS FCFCHRD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B -2B -3B

1.2 Ratios

CHRD has a better Return On Assets (6.63%) than 69.95% of its industry peers.
With a Return On Equity value of 10.04%, CHRD perfoms like the industry average, outperforming 58.69% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 7.76%, CHRD is in the better half of the industry, outperforming 64.32% of the companies in the same industry.
CHRD had an Average Return On Invested Capital over the past 3 years of 15.70%. This is significantly below the industry average of 23.55%.
The 3 year average ROIC (15.70%) for CHRD is well above the current ROIC(7.76%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 6.63%
ROE 10.04%
ROIC 7.76%
ROA(3y)16.4%
ROA(5y)-22.23%
ROE(3y)23.16%
ROE(5y)-60.5%
ROIC(3y)15.7%
ROIC(5y)15.04%
CHRD Yearly ROA, ROE, ROICCHRD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

The Profit Margin of CHRD (16.08%) is better than 65.26% of its industry peers.
CHRD's Profit Margin has declined in the last couple of years.
CHRD has a Operating Margin (21.26%) which is comparable to the rest of the industry.
CHRD's Operating Margin has improved in the last couple of years.
The Gross Margin of CHRD (54.83%) is better than 61.97% of its industry peers.
CHRD's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 21.26%
PM (TTM) 16.08%
GM 54.83%
OM growth 3Y-17.8%
OM growth 5Y20.31%
PM growth 3Y-7.34%
PM growth 5YN/A
GM growth 3Y-4.26%
GM growth 5Y-3.06%
CHRD Yearly Profit, Operating, Gross MarginsCHRD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CHRD is creating some value.
The number of shares outstanding for CHRD has been increased compared to 1 year ago.
The number of shares outstanding for CHRD has been reduced compared to 5 years ago.
The debt/assets ratio for CHRD is higher compared to a year ago.
CHRD Yearly Shares OutstandingCHRD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
CHRD Yearly Total Debt VS Total AssetsCHRD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

Based on the Altman-Z score of 1.76, we must say that CHRD is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.76, CHRD perfoms like the industry average, outperforming 59.62% of the companies in the same industry.
CHRD has a debt to FCF ratio of 1.95. This is a very positive value and a sign of high solvency as it would only need 1.95 years to pay back of all of its debts.
CHRD's Debt to FCF ratio of 1.95 is amongst the best of the industry. CHRD outperforms 84.04% of its industry peers.
A Debt/Equity ratio of 0.09 indicates that CHRD is not too dependend on debt financing.
CHRD has a Debt to Equity ratio of 0.09. This is in the better half of the industry: CHRD outperforms 77.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 1.95
Altman-Z 1.76
ROIC/WACC0.89
WACC8.74%
CHRD Yearly LT Debt VS Equity VS FCFCHRD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 0.89 indicates that CHRD may have some problems paying its short term obligations.
CHRD has a Current ratio of 0.89. This is in the lower half of the industry: CHRD underperforms 63.38% of its industry peers.
A Quick Ratio of 0.83 indicates that CHRD may have some problems paying its short term obligations.
The Quick ratio of CHRD (0.83) is worse than 60.56% of its industry peers.
Industry RankSector Rank
Current Ratio 0.89
Quick Ratio 0.83
CHRD Yearly Current Assets VS Current LiabilitesCHRD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

CHRD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -17.96%.
Measured over the past 5 years, CHRD shows a small growth in Earnings Per Share. The EPS has been growing by 1.52% on average per year.
Looking at the last year, CHRD shows a very strong growth in Revenue. The Revenue has grown by 31.71%.
Measured over the past years, CHRD shows a very strong growth in Revenue. The Revenue has been growing by 20.44% on average per year.
EPS 1Y (TTM)-17.96%
EPS 3Y1.52%
EPS 5YN/A
EPS Q2Q%-20.78%
Revenue 1Y (TTM)31.71%
Revenue growth 3Y49.24%
Revenue growth 5Y20.44%
Sales Q2Q%11.96%

3.2 Future

The Earnings Per Share is expected to decrease by -3.28% on average over the next years.
CHRD is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -3.86% yearly.
EPS Next Y-35.72%
EPS Next 2Y-19.29%
EPS Next 3Y-7.1%
EPS Next 5Y-3.28%
Revenue Next Year-10.62%
Revenue Next 2Y-5.63%
Revenue Next 3Y-3.86%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CHRD Yearly Revenue VS EstimatesCHRD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
CHRD Yearly EPS VS EstimatesCHRD Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 10 20 30

7

4. Valuation

4.1 Price/Earnings Ratio

CHRD is valuated cheaply with a Price/Earnings ratio of 6.66.
Compared to the rest of the industry, the Price/Earnings ratio of CHRD indicates a rather cheap valuation: CHRD is cheaper than 85.92% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.35, CHRD is valued rather cheaply.
With a Price/Forward Earnings ratio of 9.58, the valuation of CHRD can be described as very reasonable.
CHRD's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CHRD is cheaper than 69.01% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CHRD to the average of the S&P500 Index (22.19), we can say CHRD is valued rather cheaply.
Industry RankSector Rank
PE 6.66
Fwd PE 9.58
CHRD Price Earnings VS Forward Price EarningsCHRD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CHRD is valued cheaply inside the industry as 91.55% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, CHRD is valued a bit cheaper than 63.38% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.7
EV/EBITDA 2.8
CHRD Per share dataCHRD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100

4.3 Compensation for Growth

The decent profitability rating of CHRD may justify a higher PE ratio.
CHRD's earnings are expected to decrease with -7.10% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-19.29%
EPS Next 3Y-7.1%

5

5. Dividend

5.1 Amount

CHRD has a Yearly Dividend Yield of 4.98%, which is a nice return.
Compared to an average industry Dividend Yield of 6.54, CHRD pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.40, CHRD pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.98%

5.2 History

CHRD has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CHRD Yearly Dividends per shareCHRD Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 5 10 15 20 25

5.3 Sustainability

53.63% of the earnings are spent on dividend by CHRD. This is a bit on the high side, but may be sustainable.
DP53.63%
EPS Next 2Y-19.29%
EPS Next 3Y-7.1%
CHRD Yearly Income VS Free CF VS DividendCHRD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B
CHRD Dividend Payout.CHRD Dividend Payout, showing the Payout Ratio.CHRD Dividend Payout.PayoutRetained Earnings

CHORD ENERGY CORP

NASDAQ:CHRD (6/20/2025, 8:24:25 PM)

After market: 104.08 0 (0%)

104.08

-0.51 (-0.49%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners93.48%
Inst Owner ChangeN/A
Ins Owners0.89%
Ins Owner Change-8.64%
Market Cap6.01B
Analysts82.73
Price Target137.19 (31.81%)
Short Float %4.06%
Short Ratio2.7
Dividend
Industry RankSector Rank
Dividend Yield 4.98%
Yearly Dividend10.46
Dividend Growth(5Y)N/A
DP53.63%
Div Incr Years0
Div Non Decr Years0
Ex-Date05-21 2025-05-21 (1.3)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.29%
Min EPS beat(2)12.65%
Max EPS beat(2)21.92%
EPS beat(4)2
Avg EPS beat(4)3.86%
Min EPS beat(4)-11.89%
Max EPS beat(4)21.92%
EPS beat(8)4
Avg EPS beat(8)1.85%
EPS beat(12)5
Avg EPS beat(12)0.9%
EPS beat(16)9
Avg EPS beat(16)7.34%
Revenue beat(2)1
Avg Revenue beat(2)7.48%
Min Revenue beat(2)-2.64%
Max Revenue beat(2)17.6%
Revenue beat(4)3
Avg Revenue beat(4)11.94%
Min Revenue beat(4)-2.64%
Max Revenue beat(4)23.6%
Revenue beat(8)7
Avg Revenue beat(8)19.43%
Revenue beat(12)11
Avg Revenue beat(12)27.85%
Revenue beat(16)15
Avg Revenue beat(16)34.39%
PT rev (1m)-3.44%
PT rev (3m)-19%
EPS NQ rev (1m)-7.81%
EPS NQ rev (3m)-36.76%
EPS NY rev (1m)0%
EPS NY rev (3m)-17.92%
Revenue NQ rev (1m)-3.17%
Revenue NQ rev (3m)-10.55%
Revenue NY rev (1m)-1.83%
Revenue NY rev (3m)-7.02%
Valuation
Industry RankSector Rank
PE 6.66
Fwd PE 9.58
P/S 1.12
P/FCF 14.7
P/OCF 2.56
P/B 0.7
P/tB 0.74
EV/EBITDA 2.8
EPS(TTM)15.62
EY15.01%
EPS(NY)10.87
Fwd EY10.44%
FCF(TTM)7.08
FCFY6.8%
OCF(TTM)40.65
OCFY39.05%
SpS93.18
BVpS149.24
TBVpS140.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.63%
ROE 10.04%
ROCE 10.16%
ROIC 7.76%
ROICexc 7.79%
ROICexgc 8.17%
OM 21.26%
PM (TTM) 16.08%
GM 54.83%
FCFM 7.6%
ROA(3y)16.4%
ROA(5y)-22.23%
ROE(3y)23.16%
ROE(5y)-60.5%
ROIC(3y)15.7%
ROIC(5y)15.04%
ROICexc(3y)17%
ROICexc(5y)16.36%
ROICexgc(3y)17.12%
ROICexgc(5y)16.47%
ROCE(3y)20.55%
ROCE(5y)19.7%
ROICexcg growth 3Y-34.65%
ROICexcg growth 5Y32.44%
ROICexc growth 3Y-35.69%
ROICexc growth 5Y31.18%
OM growth 3Y-17.8%
OM growth 5Y20.31%
PM growth 3Y-7.34%
PM growth 5YN/A
GM growth 3Y-4.26%
GM growth 5Y-3.06%
F-Score5
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 1.95
Debt/EBITDA 0.33
Cap/Depr 150.42%
Cap/Sales 36.02%
Interest Coverage 250
Cash Conversion 96.5%
Profit Quality 47.27%
Current Ratio 0.89
Quick Ratio 0.83
Altman-Z 1.76
F-Score5
WACC8.74%
ROIC/WACC0.89
Cap/Depr(3y)173.67%
Cap/Depr(5y)227.89%
Cap/Sales(3y)27.34%
Cap/Sales(5y)32.88%
Profit Quality(3y)53.44%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-17.96%
EPS 3Y1.52%
EPS 5YN/A
EPS Q2Q%-20.78%
EPS Next Y-35.72%
EPS Next 2Y-19.29%
EPS Next 3Y-7.1%
EPS Next 5Y-3.28%
Revenue 1Y (TTM)31.71%
Revenue growth 3Y49.24%
Revenue growth 5Y20.44%
Sales Q2Q%11.96%
Revenue Next Year-10.62%
Revenue Next 2Y-5.63%
Revenue Next 3Y-3.86%
Revenue Next 5YN/A
EBIT growth 1Y-6.45%
EBIT growth 3Y22.68%
EBIT growth 5Y44.91%
EBIT Next Year102.48%
EBIT Next 3Y30.34%
EBIT Next 5Y22.79%
FCF growth 1Y-72.22%
FCF growth 3Y33.26%
FCF growth 5Y149.9%
OCF growth 1Y10.35%
OCF growth 3Y31.89%
OCF growth 5Y18.62%